Infectious Disease Diagnostics – News and Features

The supply agreement covers molecular sample and assay technologies for a national PCR-based blood screening program for HIV and HCV.

The agreement to supply molecular sample and assay technologies for a PCR-based blood screening program for HIV HCV in Brazil.

Researchers have identified a protein, called Menainv, which is a candidate for a metastatic breast cancer marker.

The University of Iowa-led study has found a new gene associated with the brain disorder that could help in overall epilepsy treatment.

Both parties collaborate to commercialize CE marked IVD infectious disease kits based on Nanogen’s proprietary MGB technology.

The Nobel Prize-winning discovery of the causal link between human papillomavirus (HPV) and cervical cancer has spurred lifesaving prevention technologies – such as HPV testing and HPV vaccines - that are helping to eradicate cervical cancer globally.

PMC appreciates the U.S. FDA’s decision to expand the black box warning on abacavir, a drug used to treat HIV infection.

CE marked under the European In Vitro Diagnostics Directive for the identification of toxigenic Clostridium difficile.

New agreement provides for development and promotion of OraQuick® HCV test outside the United States.

Both technologies are developed by scientists at the University of Colorado at Boulder in close collaboration with the U.S. Centers for Disease Control and Prevention.